Search alternatives:
"_ largest decrease" » "_ marked decrease" (Expand Search), "_ large decrease" (Expand Search)
"ct values decrease" » "ct values increased" (Expand Search), "_ values decrease" (Expand Search), "i values decrease" (Expand Search)
"_ larger decrease" » "_ marked decrease" (Expand Search), "_ large decrease" (Expand Search), "a large decrease" (Expand Search)
Showing 1 - 20 results of 110 for search '(("ct values decrease") OR ((("_ largest decrease") OR ("_ larger decrease"))))*', query time: 0.34s Refine Results
  1. 1
    Average change in trust in science by country (n = 10,000).

    Average change in trust in science by country (n = 10,000). by Alain Abi-Rizk (8549358)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Trust change by gender.

    Trust change by gender. by Alain Abi-Rizk (8549358)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Trust change by age group.

    Trust change by age group. by Alain Abi-Rizk (8549358)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Multiple linear regression analysis of trust change predictors.

    Multiple linear regression analysis of trust change predictors. by Alain Abi-Rizk (8549358)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Distribution of individual change in trust in science before and after the pandemic (n = 10,000).

    Distribution of individual change in trust in science before and after the pandemic (n = 10,000). by Alain Abi-Rizk (8549358)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Trust change by education level.

    Trust change by education level. by Alain Abi-Rizk (8549358)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Trust change by source of science information.

    Trust change by source of science information. by Alain Abi-Rizk (8549358)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Post-pandemic trust in science survey.

    Post-pandemic trust in science survey. by Alain Abi-Rizk (8549358)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Trust levels before and after the COVID-19 pandemic (n = 10,000).

    Trust levels before and after the COVID-19 pandemic (n = 10,000). by Alain Abi-Rizk (8549358)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24.

    Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART.

    Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model.

    Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24.

    Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24.

    Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Consolidated Standards of Reporting Trials flow diagram for participants in the trial.

    Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: